The lawsuit claims that three major healthcare companies were pushing up the price of insulin by 1,200 percent.

(Reuters) -Cigna Group plans to make changes to help lower out-of-pocket cost of prescription drugs, the company said on ...

Fresh off underperforming Wall Street’s expectations in the fourth quarter, Cigna said it would work to lower costs for its ...

In a recent antitrust arbitration ruling, Prime Therapeutics, a pharmacy benefit manager (PBM) owned by 19 Blue Cross and ...

Express Scripts aims to ensure that patients directly benefit from its negotiations with drug manufacturers. The new approach will protect patients from paying inflated list prices for medications, ...

Witty's comments came during the company's first earnings call since the killing of Brian Thompson, the CEO of the company's ...

FTC stated that the 'Big 3' PBM organisations collectively generated over £5.94 billion ($7.3 billion) in revenue from 2017 to 2022.

Investing.com -- Shares of CVS Health Corp (NYSE:CVS), Cigna (NYSE:CI) Group, and UnitedHealth ... Cigna’s Express Scripts, and UnitedHealth’s OptumRx — imposed markups of hundreds to ...

Pharmacy benefit managers CVS Caremark, OptumRx and Express Scripts inflated costs ... The CVS Health subsidiary, UnitedHealth Group division and Cigna subsidiary employed tactics such as marking ...

Discover how the three largest pharmacy benefit managers are rejecting biosimilars from their formularies, except for their own private-label drugs.

UnitedHealth Group operates a top-tier health insurer ... and Cigna, which added Express Scripts' PBM assets to its medical insurance operations. With the alignment of these interests, we think ...